Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Acrux ( (AU:ACR) ).
Acrux Limited has announced the appointment of John Warmbrunn as the new CEO and Managing Director, effective June 1, 2025, following the retirement of Michael Kotsanis. Warmbrunn brings over 25 years of experience in the healthcare sector, with a strong track record in international business growth and leadership roles at companies like Ego Pharmaceuticals and Bendigo Community Telco. His appointment is expected to drive Acrux’s next phase of growth, particularly in expanding its international market presence.
More about Acrux
Acrux Limited operates in the pharmaceutical industry, focusing on developing and marketing topical generic pharmaceutical products. The company is expanding its range of marketed products internationally, aiming to leverage its expertise in bringing products to market.
Average Trading Volume: 244,310
Technical Sentiment Signal: Sell
Current Market Cap: A$9.37M
See more insights into ACR stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue